Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Decreases By 41.2%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 2,000 shares, a decline of 41.2% from the February 13th total of 3,400 shares. Based on an average daily trading volume, of 9,100 shares, the short-interest ratio is currently 0.2 days.

Lexaria Bioscience Stock Performance

NASDAQ:LEXXW traded up $0.06 on Friday, reaching $0.26. The stock had a trading volume of 11,005 shares, compared to its average volume of 13,173. Lexaria Bioscience has a 12-month low of $0.16 and a 12-month high of $2.07. The company has a 50-day moving average of $0.39 and a 200 day moving average of $0.69.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.